Literature DB >> 22748211

Gene patents in the US--focusing on what really matters.

Allison W Dobson, James P Evans.   

Abstract

With new technologies, concerns about gene patent claims regarding isolated DNA are becoming less relevant, but broad method claims could be more problematic.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22748211      PMCID： PMC3446309          DOI： 10.1186/gb-2012-13-6-161

Source DB:  PubMed          Journal:  Genome Biol        ISSN： 1474-7596            Impact factor:   13.583


  3 in total

1.  Debunking the myth that whole-genome sequencing infringes thousands of gene patents.

Authors:  Christopher M Holman
Journal:  Nat Biotechnol       Date:  2012-03-07       Impact factor: 54.908

2.  Is there still a place for gene patents in Australia? Implications of recent United States and European case law.

Authors:  Alexandra Ridley; Dianne Nicol
Journal:  J Law Med       Date:  2011-12

3.  Gene and genetic diagnostic method patent claims: a comparison under current European and US patent law.

Authors:  Isabelle Huys; Geertrui Van Overwalle; Gert Matthijs
Journal:  Eur J Hum Genet       Date:  2011-06-08       Impact factor: 4.246
  3 in total
  1 in total

1.  Transparency tools in gene patenting for informing policy and practice.

Authors:  Osmat A Jefferson; Deniz Köllhofer; Thomas H Ehrich; Richard A Jefferson
Journal:  Nat Biotechnol       Date:  2013-12       Impact factor: 54.908
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.